Loading...
Header Logo
Keywords
Last Name
Institution

VEERABHADRAN BALADANDAYUTHAPANI

TitleAssociate Professor
InstitutionMD Anderson
DepartmentBiostatistics
vCardDownload vCard

    Collapse ORNG Applications 
    Collapse Verify Publications

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Maity AK, Bhattacharya A, Mallick BK, Baladandayuthapani V. Bayesian Data Integration and Variable Selection for Pan-Cancer Survival Prediction using Protein Expression Data. Biometrics. 2019 Aug 08. PMID: 31393003.
      View in: PubMed
    2. Marisetty AL, Lu L, Veo BL, Liu B, Coarfa C, Kamal MM, Kassem DH, Irshad K, Lu Y, Gumin J, Henry V, Paulucci-Holthauzen A, Rao G, Baladandayuthapani V, Lang FF, Fuller GN, Majumder S. REST-DRD2 mechanism impacts glioblastoma stem cell-mediated tumorigenesis. Neuro Oncol. 2019 Jun 10; 21(6):775-785. PMID: 30953587.
      View in: PubMed
    3. Gates EDH, Lin JS, Weinberg JS, Hamilton J, Prabhu SS, Hazle JD, Fuller GN, Baladandayuthapani V, Fuentes D, Schellingerhout D. Guiding the first biopsy in glioma patients using estimated Ki-67 maps derived from MRI: conventional versus advanced imaging. Neuro Oncol. 2019 Mar 18; 21(4):527-536. PMID: 30657997.
      View in: PubMed
    4. Ha MJ, Banerjee S, Akbani R, Liang H, Mills GB, Do KA, Baladandayuthapani V. Personalized Integrated Network Modeling of the Cancer Proteome Atlas. Sci Rep. 2018 Oct 08; 8(1):14924. PMID: 30297783.
      View in: PubMed
    5. Ruder D, Papadimitrakopoulou V, Shien K, Behrens C, Kalhor N, Chen H, Shen L, Lee JJ, Hong WK, Tang X, Girard L, Minna JD, Diao L, Wang J, Mino B, Villalobos P, Rodriguez-Canales J, Hanson NE, Sun J, Miller V, Greenbowe J, Frampton G, Herbst RS, Baladandayuthapani V, Wistuba II, Izzo JG. Concomitant targeting of the mTOR/MAPK pathways: novel therapeutic strategy in subsets of RICTOR/KRAS-altered non-small cell lung cancer. Oncotarget. 2018 Sep 21; 9(74):33995-34008. PMID: 30338041.
      View in: PubMed
    6. Ni H, Shirazi F, Baladandayuthapani V, Lin H, Kuiatse I, Wang H, Jones RJ, Berkova Z, Hitoshi Y, Ansell SM, Treon SP, Thomas SK, Lee HC, Wang Z, Davis RE, Orlowski RZ. Targeting Myddosome Signaling in Waldenström's Macroglobulinemia with the Interleukin-1 Receptor-Associated Kinase 1/4 Inhibitor R191. Clin Cancer Res. 2018 Dec 15; 24(24):6408-6420. PMID: 30126942.
      View in: PubMed
    7. Elhalawani H, Lin TA, Volpe S, Mohamed ASR, White AL, Zafereo J, Wong AJ, Berends JE, AboHashem S, Williams B, Aymard JM, Kanwar A, Perni S, Rock CD, Cooksey L, Campbell S, Yang P, Nguyen K, Ger RB, Cardenas CE, Fave XJ, Sansone C, Piantadosi G, Marrone S, Liu R, Huang C, Yu K, Li T, Yu Y, Zhang Y, Zhu H, Morris JS, Baladandayuthapani V, Shumway JW, Ghosh A, Pöhlmann A, Phoulady HA, Goyal V, Canahuate G, Marai GE, Vock D, Lai SY, Mackin DS, Court LE, Freymann J, Farahani K, Kaplathy-Cramer J, Fuller CD. Machine Learning Applications in Head and Neck Radiation Oncology: Lessons From Open-Source Radiomics Challenges. Front Oncol. 2018; 8:294. PMID: 30175071.
      View in: PubMed
    8. Ni Y, Stingo FC, Ha MJ, Akbani R, Baladandayuthapani V. Bayesian Hierarchical Varying-sparsity Regression Models with Application to Cancer Proteogenomics. J Am Stat Assoc. 2019; 114(525):48-60. PMID: 31178611.
      View in: PubMed
    9. Lee W, Miranda MF, Rausch P, Baladandayuthapani V, Fazio M, Downs JC, Morris JS. Bayesian Semiparametric Functional Mixed Models for Serially Correlated Functional Data, with Application to Glaucoma Data. J Am Stat Assoc. 2019; 114(526):495-513. PMID: 31235987.
      View in: PubMed
    10. Kundu S, Cheng Y, Shin M, Manyam G, Mallick BK, Baladandayuthapani V. Bayesian variable selection with graphical structure learning: Applications in integrative genomics. PLoS One. 2018; 13(7):e0195070. PMID: 30059495.
      View in: PubMed
    11. Zinn PO, Singh SK, Kotrotsou A, Hassan I, Thomas G, Luedi MM, Elakkad A, Elshafeey N, Idris T, Mosley J, Gumin J, Fuller GN, de Groot JF, Baladandayuthapani V, Sulman EP, Kumar AJ, Sawaya R, Lang FF, Piwnica-Worms D, Colen RR. A Coclinical Radiogenomic Validation Study: Conserved Magnetic Resonance Radiomic Appearance of Periostin-Expressing Glioblastoma in Patients and Xenograft Models. Clin Cancer Res. 2018 Dec 15; 24(24):6288-6299. PMID: 30054278.
      View in: PubMed
    12. Kappadath SC, Mikell J, Balagopal A, Baladandayuthapani V, Kaseb A, Mahvash A. Hepatocellular Carcinoma Tumor Dose Response After 90Y-radioembolization With Glass Microspheres Using 90Y-SPECT/CT-Based Voxel Dosimetry. Int J Radiat Oncol Biol Phys. 2018 10 01; 102(2):451-461. PMID: 30191875.
      View in: PubMed
    13. Davenport CA, Maity A, Baladandayuthapani V. Functional interaction-based nonlinear models with application to multiplatform genomics data. Stat Med. 2018 Aug 15; 37(18):2715-2733. PMID: 29737021.
      View in: PubMed
    14. Class CA, Ha MJ, Baladandayuthapani V, Do KA. iDINGO-integrative differential network analysis in genomics with Shiny application. Bioinformatics. 2018 04 01; 34(7):1243-1245. PMID: 29194470.
      View in: PubMed
    15. Zhang X, Lee HC, Shirazi F, Baladandayuthapani V, Lin H, Kuiatse I, Wang H, Jones RJ, Berkova Z, Singh RK, Lu J, Qian Y, Raina K, Coleman KG, Crews CM, Li B, Wang H, Hailemichael Y, Thomas SK, Wang Z, Davis RE, Orlowski RZ. Protein targeting chimeric molecules specific for bromodomain and extra-terminal motif family proteins are active against pre-clinical models of multiple myeloma. Leukemia. 2018 10; 32(10):2224-2239. PMID: 29581547.
      View in: PubMed
    16. Bharath K, Kurtek S, Rao A, Baladandayuthapani V. Radiologic image-based statistical shape analysis of brain tumours. J R Stat Soc Ser C Appl Stat. 2018 Nov; 67(5):1357-1378. PMID: 30420787.
      View in: PubMed
    17. Meraz IM, Majidi M, Cao X, Lin H, Li L, Wang J, Baladandayuthapani V, Rice D, Sepesi B, Ji L, Roth JA. TUSC2 Immunogene Therapy Synergizes with Anti-PD-1 through Enhanced Proliferation and Infiltration of Natural Killer Cells in Syngeneic Kras-Mutant Mouse Lung Cancer Models. Cancer Immunol Res. 2018 02; 6(2):163-177. PMID: 29339375.
      View in: PubMed
    18. Shoemaker K, Hobbs BP, Bharath K, Ng CS, Baladandayuthapani V. Tree-based Methods for Characterizing Tumor Density Heterogeneity. Pac Symp Biocomput. 2018; 23:216-227. PMID: 29218883.
      View in: PubMed
    19. Wang H, Baladandayuthapani V, Wang Z, Lin H, Berkova Z, Davis RE, Yang L, Orlowski RZ. Truncated protein tyrosine phosphatase receptor type O suppresses AKT signaling through IQ motif containing GTPase activating protein 1 and confers sensitivity to bortezomib in multiple myeloma. Oncotarget. 2017 Dec 26; 8(69):113858-113873. PMID: 29371952.
      View in: PubMed
    20. Zhu B, Song N, Shen R, Arora A, Machiela MJ, Song L, Landi MT, Ghosh D, Chatterjee N, Baladandayuthapani V, Zhao H. Integrating Clinical and Multiple Omics Data for Prognostic Assessment across Human Cancers. Sci Rep. 2017 12 05; 7(1):16954. PMID: 29209073.
      View in: PubMed
    21. Yu K, Zhang Y, Yu Y, Huang C, Liu R, Li T, Yang L, Morris JS, Baladandayuthapani V, Zhu H. Radiomic analysis in prediction of Human Papilloma Virus status. Clin Transl Radiat Oncol. 2017 Dec; 7:49-54. PMID: 29594229.
      View in: PubMed
    22. Morris JS, Baladandayuthapani V. Rejoinder to statistical contributions to bioinformatics: Design, modelling, structure learning and Integration. Stat Modelling. 2017 Aug; 17(4-5):338-357. PMID: 30034293.
      View in: PubMed
    23. Wadhwa R, Wang X, Baladandayuthapani V, Liu B, Shiozaki H, Shimodaira Y, Lin Q, Elimova E, Hofstetter WL, Swisher SG, Rice DC, Maru DM, Kalhor N, Bhutani MS, Weston B, Lee JH, Skinner HD, Scott AW, Kaya DM, Harada K, Berry D, Song S, Ajani JA. Nuclear expression of Gli-1 is predictive of pathologic complete response to chemoradiation in trimodality treated oesophageal cancer patients. Br J Cancer. 2017 Aug 22; 117(5):648-655. PMID: 28728163.
      View in: PubMed
    24. Gentile E, Oba T, Lin J, Shao R, Meng F, Cao X, Lin HY, Mourad M, Pataer A, Baladandayuthapani V, Cai D, Roth JA, Ji L. Cationic liquid crystalline nanoparticles for the delivery of synthetic RNAi-based therapeutics. Oncotarget. 2017 Jul 18; 8(29):48222-48239. PMID: 28637023.
      View in: PubMed
    25. Morris JS, Baladandayuthapani V. Statistical Contributions to Bioinformatics: Design, Modeling, Structure Learning, and Integration. Stat Modelling. 2017; 17(4-5):245-289. PMID: 29129969.
      View in: PubMed
    26. Ye X, Wang R, Bhattacharya R, Boulbes DR, Fan F, Xia L, Adoni H, Ajami NJ, Wong MC, Smith DP, Petrosino JF, Venable S, Qiao W, Baladandayuthapani V, Maru D, Ellis LM. Fusobacterium Nucleatum Subspecies Animalis Influences Proinflammatory Cytokine Expression and Monocyte Activation in Human Colorectal Tumors. Cancer Prev Res (Phila). 2017 Jul; 10(7):398-409. PMID: 28483840.
      View in: PubMed
    27. Bhadra A, Rao A, Baladandayuthapani V. Inferring network structure in non-normal and mixed discrete-continuous genomic data. Biometrics. 2018 03; 74(1):185-195. PMID: 28437848.
      View in: PubMed
    28. Lee HC, Wang H, Baladandayuthapani V, Lin H, He J, Jones RJ, Kuiatse I, Gu D, Wang Z, Ma W, Lim J, O'Brien S, Keats J, Yang J, Davis RE, Orlowski RZ. RNA Polymerase I Inhibition with CX-5461 as a Novel Therapeutic Strategy to Target MYC in Multiple Myeloma. Br J Haematol. 2017 04; 177(1):80-94. PMID: 28369725.
      View in: PubMed
    29. Baljevic M, Zaman S, Baladandayuthapani V, Lin YH, de Partovi CM, Berkova Z, Amini B, Thomas SK, Shah JJ, Weber DM, Fu M, Cleeland CS, Wang XS, Stellrecht CM, Davis RE, Gandhi V, Orlowski RZ. Phase II study of the c-MET inhibitor tivantinib (ARQ 197) in patients with relapsed or relapsed/refractory multiple myeloma. Ann Hematol. 2017 Jun; 96(6):977-985. PMID: 28337527.
      View in: PubMed
    30. Xiaobo C, Majidi M, Feng M, Shao R, Wang J, Zhao Y, Baladandayuthapani V, Song J, Fang B, Ji L, Mehran R, Roth JA. TUSC2(FUS1)-erlotinib Induced Vulnerabilities in Epidermal Growth Factor Receptor(EGFR) Wildtype Non-small Cell Lung Cancer(NSCLC) Targeted by the Repurposed Drug Auranofin. Sci Rep. 2016 11 15; 6:35741. PMID: 27845352.
      View in: PubMed
    31. Roszik J, Haydu LE, Hess KR, Oba J, Joon AY, Siroy AE, Karpinets TV, Stingo FC, Baladandayuthapani V, Tetzlaff MT, Wargo JA, Chen K, Forget MA, Haymaker CL, Chen JQ, Meric-Bernstam F, Eterovic AK, Shaw KR, Mills GB, Gershenwald JE, Radvanyi LG, Hwu P, Futreal PA, Gibbons DL, Lazar AJ, Bernatchez C, Davies MA, Woodman SE. Novel algorithmic approach predicts tumor mutation load and correlates with immunotherapy clinical outcomes using a defined gene mutation set. BMC Med. 2016 10 25; 14(1):168. PMID: 27776519.
      View in: PubMed
    32. Phillip CJ, Zaman S, Shentu S, Balakrishnan K, Zhang J, Baladandayuthapani V, Taverna P, Redkar S, Wang M, Stellrecht CM, Gandhi V. Erratum to: Targeting MET kinase with the small-molecule inhibitor amuvatinib induces cytotoxicity in primary myeloma cells and cell lines. J Hematol Oncol. 2016 10 13; 9(1):110. PMID: 27737688.
      View in: PubMed
    33. Kim S, Baladandayuthapani V, Lee JJ. Prediction-Oriented Marker Selection (PROMISE): With Application to High-Dimensional Regression. Stat Biosci. 2017 Jun; 9(1):217-245. PMID: 28785367.
      View in: PubMed
    34. Bock F, Lu G, Srour SA, Gaballa S, Lin HY, Baladandayuthapani V, Honhar M, Stich M, Shah ND, Bashir Q, Patel K, Popat U, Hosing C, Korbling M, Delgado R, Rondon G, Shah JJ, Thomas SK, Manasanch EE, Isermann B, Orlowski RZ, Champlin RE, Qazilbash MH. Outcome of Patients with Multiple Myeloma and CKS1B Gene Amplification after Autologous Hematopoietic Stem Cell Transplantation. Biol Blood Marrow Transplant. 2016 12; 22(12):2159-2164. PMID: 27638366.
      View in: PubMed
    35. Zhang L, Baladandayuthapani V, Zhu H, Baggerly KA, Majewski T, Czerniak BA, Morris JS. Functional CAR models for large spatially correlated functional datasets. J Am Stat Assoc. 2016; 111(514):772-786. PMID: 28018013.
      View in: PubMed
    36. Mikell JK, Mahvash A, Siman W, Baladandayuthapani V, Mourtada F, Kappadath SC. Selective Internal Radiation Therapy With Yttrium-90 Glass Microspheres: Biases and Uncertainties in Absorbed Dose Calculations Between Clinical Dosimetry Models. Int J Radiat Oncol Biol Phys. 2016 11 15; 96(4):888-896. PMID: 27623307.
      View in: PubMed
    37. Jones RJ, Iempridee T, Wang X, Lee HC, Mertz JE, Kenney SC, Lin HC, Baladandayuthapani V, Dawson CW, Shah JJ, Weber DM, Orlowski RZ. Lenalidomide, Thalidomide, and Pomalidomide Reactivate the Epstein-Barr Virus Lytic Cycle through Phosphoinositide 3-Kinase Signaling and Ikaros Expression. Clin Cancer Res. 2016 Oct 01; 22(19):4901-4912. PMID: 27297582.
      View in: PubMed
    38. Saha A, Banerjee S, Kurtek S, Narang S, Lee J, Rao G, Martinez J, Bharath K, Rao AU, Baladandayuthapani V. DEMARCATE: Density-based magnetic resonance image clustering for assessing tumor heterogeneity in cancer. Neuroimage Clin. 2016; 12:132-43. PMID: 27408798.
      View in: PubMed
    39. Zhang XD, Baladandayuthapani V, Lin H, Mulligan G, Li B, Esseltine DW, Qi L, Xu J, Hunziker W, Barlogie B, Usmani SZ, Zhang Q, Crowley J, Hoering A, Shah JJ, Weber DM, Manasanch EE, Thomas SK, Li BZ, Wang HH, Zhang J, Kuiatse I, Tang JL, Wang H, He J, Yang J, Milan E, Cenci S, Ma WC, Wang ZQ, Davis RE, Yang L, Orlowski RZ. Tight Junction Protein 1 Modulates Proteasome Capacity and Proteasome Inhibitor Sensitivity in Multiple Myeloma via EGFR/JAK1/STAT3 Signaling. Cancer Cell. 2016 05 09; 29(5):639-652. PMID: 27132469.
      View in: PubMed
    40. Zoh RS, Mallick B, Ivanov I, Baladandayuthapani V, Manyam G, Chapkin RS, Lampe JW, Carroll RJ. PCAN: Probabilistic correlation analysis of two non-normal data sets. Biometrics. 2016 12; 72(4):1358-1368. PMID: 27037601.
      View in: PubMed
    41. Sathyan P, Zinn PO, Marisetty AL, Liu B, Kamal MM, Singh SK, Bady P, Lu L, Wani KM, Veo BL, Gumin J, Kassem DH, Robinson F, Weng C, Baladandayuthapani V, Suki D, Colman H, Bhat KP, Sulman EP, Aldape K, Colen RR, Verhaak RG, Lu Z, Fuller GN, Huang S, Lang FF, Sawaya R, Hegi M, Majumder S. Mir-21-Sox2 Axis Delineates Glioblastoma Subtypes with Prognostic Impact. J Neurosci. 2015 Nov 11; 35(45):15097-112. PMID: 26558781.
      View in: PubMed
    42. Azadeh S, Hobbs BP, Ma L, Nielsen DA, Gerard Moeller F, Baladandayuthapani V. Integrative Bayesian analysis of neuroimaging-genetic data with application to cocaine dependence. Neuroimage. 2016 Jan 15; 125:813-824. PMID: 26484829.
      View in: PubMed
    43. Zhang S, Lu Z, Mao W, Ahmed AA, Yang H, Zhou J, Jennings N, Rodriguez-Aguayo C, Lopez-Berestein G, Miranda R, Qiao W, Baladandayuthapani V, Li Z, Sood AK, Liu J, Le XF, Bast RC. CDK5 Regulates Paclitaxel Sensitivity in Ovarian Cancer Cells by Modulating AKT Activation, p21Cip1- and p27Kip1-Mediated G1 Cell Cycle Arrest and Apoptosis. PLoS One. 2015; 10(7):e0131833. PMID: 26146988.
      View in: PubMed
    44. Ha MJ, Baladandayuthapani V, Do KA. DINGO: differential network analysis in genomics. Bioinformatics. 2015 Nov 01; 31(21):3413-20. PMID: 26148744.
      View in: PubMed
    45. Dai B, Yan S, Lara-Guerra H, Kawashima H, Sakai R, Jayachandran G, Majidi M, Mehran R, Wang J, Bekele BN, Baladandayuthapani V, Yoo SY, Wang Y, Ying J, Meng F, Ji L, Roth JA. Exogenous Restoration of TUSC2 Expression Induces Responsiveness to Erlotinib in Wildtype Epidermal Growth Factor Receptor (EGFR) Lung Cancer Cells through Context Specific Pathways Resulting in Enhanced Therapeutic Efficacy. PLoS One. 2015; 10(6):e0123967. PMID: 26053020.
      View in: PubMed
    46. Wait JM, Cody D, Jones AK, Rong J, Baladandayuthapani V, Kappadath SC. Performance Evaluation of Material Decomposition With Rapid-Kilovoltage-Switching Dual-Energy CT and Implications for Assessing Bone Mineral Density. AJR Am J Roentgenol. 2015 Jun; 204(6):1234-41. PMID: 26001233.
      View in: PubMed
    47. Gregory KB, Carroll RJ, Baladandayuthapani V, Lahiri SN. A Two-Sample Test for Equality of Means in High Dimension. J Am Stat Assoc. 2015 Jun 01; 110(510):837-849. PMID: 26279594.
      View in: PubMed
    48. Ni Y, Stingo FC, Baladandayuthapani V. Bayesian nonlinear model selection for gene regulatory networks. Biometrics. 2015 Sep; 71(3):585-95. PMID: 25854759.
      View in: PubMed
    49. Kuiatse I, Baladandayuthapani V, Lin HY, Thomas SK, Bjorklund CC, Weber DM, Wang M, Shah JJ, Zhang XD, Jones RJ, Ansell SM, Yang G, Treon SP, Orlowski RZ. Targeting the Spleen Tyrosine Kinase with Fostamatinib as a Strategy against Waldenström Macroglobulinemia. Clin Cancer Res. 2015 Jun 01; 21(11):2538-45. PMID: 25748087.
      View in: PubMed
    50. Ha MJ, Baladandayuthapani V, Do KA. Prognostic gene signature identification using causal structure learning: applications in kidney cancer. Cancer Inform. 2015; 14(Suppl 1):23-35. PMID: 25861215.
      View in: PubMed
    51. Nute JL, Le Roux L, Chandler AG, Baladandayuthapani V, Schellingerhout D, Cody DD. Differentiation of low-attenuation intracranial hemorrhage and calcification using dual-energy computed tomography in a phantom system. Invest Radiol. 2015 Jan; 50(1):9-16. PMID: 25162534.
      View in: PubMed
    52. Zhang L, Morris JS, Zhang J, Orlowski RZ, Baladandayuthapani V. Bayesian joint selection of genes and pathways: applications in multiple myeloma genomics. Cancer Inform. 2014; 13(Suppl 2):113-23. PMID: 25520554.
      View in: PubMed
    53. Fowler NH, Davis RE, Rawal S, Nastoupil L, Hagemeister FB, McLaughlin P, Kwak LW, Romaguera JE, Fanale MA, Fayad LE, Westin JR, Shah J, Orlowski RZ, Wang M, Turturro F, Oki Y, Claret LC, Feng L, Baladandayuthapani V, Muzzafar T, Tsai KY, Samaniego F, Neelapu SS. Safety and activity of lenalidomide and rituximab in untreated indolent lymphoma: an open-label, phase 2 trial. Lancet Oncol. 2014 Nov; 15(12):1311-8. PMID: 25439689.
      View in: PubMed
    54. Guha S, Ji Y, Baladandayuthapani V. Bayesian disease classification using copy number data. Cancer Inform. 2014; 13(Suppl 2):83-91. PMID: 25336897.
      View in: PubMed
    55. Ni Y, Stingo FC, Baladandayuthapani V. Integrative bayesian network analysis of genomic data. Cancer Inform. 2014; 13(Suppl 2):39-48. PMID: 25288878.
      View in: PubMed
    56. Jiang H, An L, Baladandayuthapani V, Auer PL. Classification, predictive modelling, and statistical analysis of cancer data (a). Cancer Inform. 2014; 13(Suppl 2):1-3. PMID: 25288874.
      View in: PubMed
    57. Zhang L, Baladandayuthapani V, Mallick BK, Manyam GC, Thompson PA, Bondy ML, Do KA. Bayesian hierarchical structured variable selection methods with application to MIP studies in breast cancer. J R Stat Soc Ser C Appl Stat. 2014 Aug; 63(4):595-620. PMID: 25705056.
      View in: PubMed
    58. Pemmaraju N, Shah D, Kantarjian H, Orlowski RZ, Nogueras González GM, Baladandayuthapani V, Jain N, Wagner V, Garcia-Manero G, Shah J, Ravandi F, Pierce S, Takahashi K, Daver N, Nazha A, Verstovsek S, Jabbour E, De Lima M, Champlin R, Cortes J, Qazilbash MH. Characteristics and outcomes of patients with multiple myeloma who develop therapy-related myelodysplastic syndrome, chronic myelomonocytic leukemia, or acute myeloid leukemia. Clin Lymphoma Myeloma Leuk. 2015 Feb; 15(2):110-4. PMID: 25107338.
      View in: PubMed
    59. Wu W, Merriman K, Nabaah A, Seval N, Seval D, Lin H, Wang M, Qazilbash MH, Baladandayuthapani V, Berry D, Orlowski RZ, Lee MH, Yeung SC. The association of diabetes and anti-diabetic medications with clinical outcomes in multiple myeloma. Br J Cancer. 2014 Jul 29; 111(3):628-36. PMID: 24921909.
      View in: PubMed
    60. Gregory KB, Momin AA, Coombes KR, Baladandayuthapani V. Latent Feature Decompositions for Integrative Analysis of Multi-Platform Genomic Data. IEEE/ACM Trans Comput Biol Bioinform. 2014 Nov-Dec; 11(6):984-94. PMID: 26146492.
      View in: PubMed
    61. Voo KS, Foglietta M, Percivalle E, Chu F, Nattamai D, Harline M, Lee ST, Bover L, Lin HY, Baladandayuthapani V, Delgado D, Luong A, Davis RE, Kwak LW, Liu YJ, Neelapu SS. Selective targeting of Toll-like receptors and OX40 inhibit regulatory T-cell function in follicular lymphoma. Int J Cancer. 2014 Dec 15; 135(12):2834-46. PMID: 24771328.
      View in: PubMed
    62. El-Mabhouh AA, Ayres ML, Shpall EJ, Baladandayuthapani V, Keating MJ, Wierda WG, Gandhi V. Evaluation of bendamustine in combination with fludarabine in primary chronic lymphocytic leukemia cells. Blood. 2014 Jun 12; 123(24):3780-9. PMID: 24747434.
      View in: PubMed
    63. Talluri R, Baladandayuthapani V, Mallick BK. Bayesian sparse graphical models and their mixtures. Stat. 2014 Jan 01; 3(1):109-125. PMID: 24948842.
      View in: PubMed
    64. Baladandayuthapani V, Talluri R, Ji Y, Coombes KR, Lu Y, Hennessy BT, Davies MA, Mallick BK. BAYESIAN SPARSE GRAPHICAL MODELS FOR CLASSIFICATION WITH APPLICATION TO PROTEIN EXPRESSION DATA. Ann Appl Stat. 2014; 8(3):1443-1468. PMID: 26246866.
      View in: PubMed
    65. Westin JR, Chu F, Zhang M, Fayad LE, Kwak LW, Fowler N, Romaguera J, Hagemeister F, Fanale M, Samaniego F, Feng L, Baladandayuthapani V, Wang Z, Ma W, Gao Y, Wallace M, Vence LM, Radvanyi L, Muzzafar T, Rotem-Yehudar R, Davis RE, Neelapu SS. Safety and activity of PD1 blockade by pidilizumab in combination with rituximab in patients with relapsed follicular lymphoma: a single group, open-label, phase 2 trial. Lancet Oncol. 2014 Jan; 15(1):69-77. PMID: 24332512.
      View in: PubMed
    66. Phillip CJ, Zaman S, Shentu S, Balakrishnan K, Zhang J, Baladandayuthapani V, Taverna P, Redkar S, Wang M, Stellrecht CM, Gandhi V. Targeting MET kinase with the small-molecule inhibitor amuvatinib induces cytotoxicity in primary myeloma cells and cell lines. J Hematol Oncol. 2013 Dec 10; 6:92. PMID: 24326130.
      View in: PubMed
    67. Bailey AM, Zhan L, Maru D, Shureiqi I, Pickering CR, Kiriakova G, Izzo J, He N, Wei C, Baladandayuthapani V, Liang H, Kopetz S, Powis G, Guo GL. FXR silencing in human colon cancer by DNA methylation and KRAS signaling. Am J Physiol Gastrointest Liver Physiol. 2014 Jan 01; 306(1):G48-58. PMID: 24177031.
      View in: PubMed
    68. Ajani JA, Wang X, Song S, Suzuki A, Taketa T, Sudo K, Wadhwa R, Hofstetter WL, Komaki R, Maru DM, Lee JH, Bhutani MS, Weston B, Baladandayuthapani V, Yao Y, Honjo S, Scott AW, Skinner HD, Johnson RL, Berry D. ALDH-1 expression levels predict response or resistance to preoperative chemoradiation in resectable esophageal cancer patients. Mol Oncol. 2014 Feb; 8(1):142-9. PMID: 24210755.
      View in: PubMed
    69. Wang W, Baladandayuthapani V, Holmes CC, Do KA. Integrative network-based Bayesian analysis of diverse genomics data. BMC Bioinformatics. 2013; 14 Suppl 13:S8. PMID: 24267288.
      View in: PubMed
    70. Jennings EM, Morris JS, Carroll RJ, Manyam GC, Baladandayuthapani V. Bayesian methods for expression-based integration of various types of genomics data. EURASIP J Bioinform Syst Biol. 2013 Sep 21; 2013(1):13. PMID: 24053265.
      View in: PubMed
    71. Srivastava S, Wang W, Manyam G, Ordonez C, Baladandayuthapani V. Integrating multi-platform genomic data using hierarchical Bayesian relevance vector machines. EURASIP J Bioinform Syst Biol. 2013 Jun 28; 2013(1):9. PMID: 23809014.
      View in: PubMed
    72. Bjorklund CC, Baladandayuthapani V, Lin HY, Jones RJ, Kuiatse I, Wang H, Yang J, Shah JJ, Thomas SK, Wang M, Weber DM, Orlowski RZ. Evidence of a role for CD44 and cell adhesion in mediating resistance to lenalidomide in multiple myeloma: therapeutic implications. Leukemia. 2014 Feb; 28(2):373-83. PMID: 23760401.
      View in: PubMed
    73. Pemmaraju N, Tanaka MF, Ravandi F, Lin H, Baladandayuthapani V, Rondon G, Giralt SA, Chen J, Pierce S, Cortes J, Kantarjian H, Champlin RE, De Lima M, Qazilbash MH. Outcomes in patients with relapsed or refractory acute promyelocytic leukemia treated with or without autologous or allogeneic hematopoietic stem cell transplantation. Clin Lymphoma Myeloma Leuk. 2013 Aug; 13(4):485-92. PMID: 23769669.
      View in: PubMed
    74. Rawal S, Chu F, Zhang M, Park HJ, Nattamai D, Kannan S, Sharma R, Delgado D, Chou T, Lin HY, Baladandayuthapani V, Luong A, Vega F, Fowler N, Dong C, Davis RE, Neelapu SS. Cross talk between follicular Th cells and tumor cells in human follicular lymphoma promotes immune evasion in the tumor microenvironment. J Immunol. 2013 Jun 15; 190(12):6681-93. PMID: 23686488.
      View in: PubMed
    75. Wang W, Baladandayuthapani V, Morris JS, Broom BM, Manyam G, Do KA. iBAG: integrative Bayesian analysis of high-dimensional multiplatform genomics data. Bioinformatics. 2013 Jan 15; 29(2):149-59. PMID: 23142963.
      View in: PubMed
    76. Kuhn DJ, Berkova Z, Jones RJ, Woessner R, Bjorklund CC, Ma W, Davis RE, Lin P, Wang H, Madden TL, Wei C, Baladandayuthapani V, Wang M, Thomas SK, Shah JJ, Weber DM, Orlowski RZ. Targeting the insulin-like growth factor-1 receptor to overcome bortezomib resistance in preclinical models of multiple myeloma. Blood. 2012 Oct 18; 120(16):3260-70. PMID: 22932796.
      View in: PubMed
    77. Jones RJ, Bjorklund CC, Baladandayuthapani V, Kuhn DJ, Orlowski RZ. Drug resistance to inhibitors of the human double minute-2 E3 ligase is mediated by point mutations of p53, but can be overcome with the p53 targeting agent RITA. Mol Cancer Ther. 2012 Oct; 11(10):2243-53. PMID: 22933706.
      View in: PubMed
    78. Prasad S, Yadav VR, Sung B, Reuter S, Kannappan R, Deorukhkar A, Diagaradjane P, Wei C, Baladandayuthapani V, Krishnan S, Guha S, Aggarwal BB. Ursolic acid inhibits growth and metastasis of human colorectal cancer in an orthotopic nude mouse model by targeting multiple cell signaling pathways: chemosensitization with capecitabine. Clin Cancer Res. 2012 Sep 15; 18(18):4942-53. PMID: 22832932.
      View in: PubMed
    79. Lu C, Stewart DJ, Lee JJ, Ji L, Ramesh R, Jayachandran G, Nunez MI, Wistuba II, Erasmus JJ, Hicks ME, Grimm EA, Reuben JM, Baladandayuthapani V, Templeton NS, McMannis JD, Roth JA. Phase I clinical trial of systemically administered TUSC2(FUS1)-nanoparticles mediating functional gene transfer in humans. PLoS One. 2012; 7(4):e34833. PMID: 22558101.
      View in: PubMed
    80. Garrett CR, Hassabo HM, Bhadkamkar NA, Wen S, Baladandayuthapani V, Kee BK, Eng C, Hassan MM. Survival advantage observed with the use of metformin in patients with type II diabetes and colorectal cancer. Br J Cancer. 2012 Apr 10; 106(8):1374-8. PMID: 22421948.
      View in: PubMed
    81. Garrett CR, George B, Viswanathan C, Bhadkamkar NA, Wen S, Baladandayuthapani V, You YN, Kopetz ES, Overman MJ, Kee BK, Eng C. Survival benefit associated with surgical oophorectomy in patients with colorectal cancer metastatic to the ovary. Clin Colorectal Cancer. 2012 Sep; 11(3):191-4. PMID: 22280844.
      View in: PubMed
    82. Zheng Y, Yang J, Qian J, Zhang L, Lu Y, Li H, Lin H, Lan Y, Liu Z, He J, Hong S, Thomas S, Shah J, Baladandayuthapani V, Kwak LW, Yi Q. Novel phosphatidylinositol 3-kinase inhibitor NVP-BKM120 induces apoptosis in myeloma cells and shows synergistic anti-myeloma activity with dexamethasone. J Mol Med (Berl). 2012 Jun; 90(6):695-706. PMID: 22207485.
      View in: PubMed
    83. Jones RJ, Baladandayuthapani V, Neelapu S, Fayad LE, Romaguera JE, Wang M, Sharma R, Yang D, Orlowski RZ. HDM-2 inhibition suppresses expression of ribonucleotide reductase subunit M2, and synergistically enhances gemcitabine-induced cytotoxicity in mantle cell lymphoma. Blood. 2011 Oct 13; 118(15):4140-9. PMID: 21844567.
      View in: PubMed
    84. Thompson PA, Brewster AM, Kim-Anh D, Baladandayuthapani V, Broom BM, Edgerton ME, Hahn KM, Murray JL, Sahin A, Tsavachidis S, Wang Y, Zhang L, Hortobagyi GN, Mills GB, Bondy ML. Selective genomic copy number imbalances and probability of recurrence in early-stage breast cancer. PLoS One. 2011; 6(8):e23543. PMID: 21858162.
      View in: PubMed
    85. Morris JS, Baladandayuthapani V, Herrick RC, Sanna P, Gutstein H. AUTOMATED ANALYSIS OF QUANTITATIVE IMAGE DATA USING ISOMORPHIC FUNCTIONAL MIXED MODELS, WITH APPLICATION TO PROTEOMICS DATA. Ann Appl Stat. 2011 Jan 01; 5(2A):894-923. PMID: 22408711.
      View in: PubMed
    86. Bonato V, Baladandayuthapani V, Broom BM, Sulman EP, Aldape KD, Do KA. Bayesian ensemble methods for survival prediction in gene expression data. Bioinformatics. 2011 Feb 01; 27(3):359-67. PMID: 21148161.
      View in: PubMed
    87. Baladandayuthapani V, Ji Y, Talluri R, Nieto-Barajas LE, Morris JS. Bayesian Random Segmentation Models to Identify Shared Copy Number Aberrations for Array CGH Data. J Am Stat Assoc. 2010 Dec; 105(492):1358-1375. PMID: 21512611.
      View in: PubMed
    88. Lin YX, Baladandayuthapani V, Bonato V, Do KA. Estimating Shared Copy Number Aberrations for Array CGH Data: The Linear-Median Method. Cancer Inform. 2010 Oct 12; 9:229-49. PMID: 21082039.
      View in: PubMed
    89. Zhou L, Huang JZ, Martinez JG, Maity A, Baladandayuthapani V, Carroll RJ. Reduced Rank Mixed Effects Models for Spatially Correlated Hierarchical Functional Data. J Am Stat Assoc. 2010 Mar 01; 105(489):390-400. PMID: 20396628.
      View in: PubMed
    90. Wang J, Xu J, Baladandayuthapani V. Contrast sensitivity of digital imaging display systems: contrast threshold dependency on object type and implications for monitor quality assurance and quality control in PACS. Med Phys. 2009 Aug; 36(8):3682-92. PMID: 19746801.
      View in: PubMed
    91. Zhang N, Ge G, Meyer R, Sethi S, Basu D, Pradhan S, Zhao YJ, Li XN, Cai WW, El-Naggar AK, Baladandayuthapani V, Kittrell FS, Rao PH, Medina D, Pati D. Overexpression of Separase induces aneuploidy and mammary tumorigenesis. Proc Natl Acad Sci U S A. 2008 Sep 02; 105(35):13033-8. PMID: 18728194.
      View in: PubMed
    92. Nehete PN, Nehete BP, Hill L, Manuri PR, Baladandayuthapani V, Feng L, Simmons J, Sastry KJ. Selective induction of cell-mediated immunity and protection of rhesus macaques from chronic SHIV(KU2) infection by prophylactic vaccination with a conserved HIV-1 envelope peptide-cocktail. Virology. 2008 Jan 05; 370(1):130-41. PMID: 17920095.
      View in: PubMed
    93. Aggarwal BB, Sethi G, Baladandayuthapani V, Krishnan S, Shishodia S. Targeting cell signaling pathways for drug discovery: an old lock needs a new key. J Cell Biochem. 2007 Oct 15; 102(3):580-92. PMID: 17668425.
      View in: PubMed
    94. Baladandayuthapani V, Mallick BK, Young Hong M, Lupton JR, Turner ND, Carroll RJ. Bayesian hierarchical spatially correlated functional data analysis with application to colon carcinogenesis. Biometrics. 2008 Mar; 64(1):64-73. PMID: 17608780.
      View in: PubMed
    95. Phadke AP, de la Concha-Bermejillo A, Wolf AM, Andersen PR, Baladandayuthapani V, Collisson EW. Pathogenesis of a Texas feline immunodeficiency virus isolate: an emerging subtype of clade B. Vet Microbiol. 2006 Jun 15; 115(1-3):64-76. PMID: 16574348.
      View in: PubMed
    96. TUSC2(FUS1)-erlotinib Induced Vulnerabilities in Epidermal Growth Factor Receptor(EGFR) Wildtype Non-small Cell Lung Cancer(NSCLC) Targeted by the Repurposed Drug Auranofin. Scientific Reports. 6.
    97. DINGO. Bioinformatics. 31:3413-3420.
    98. Integrative sparse bayesian analysis of high-dimensional multi-platform genomic data in glioblastoma. 1-4.
    99. Exogenous restoration of TUSC2 expression induces responsiveness to erlotinib in wildtype epidermal growth factor receptor (EGFR) lung cancer cells through context specific pathways resulting in enhanced therapeutic efficacy. PLoS One. 10.
    100. Bayesian Methods for DNA Microarray Data Analysis. Handbook of Statistics. 25:713-742.
    101. Targeting the spleen tyrosine kinase with fostamatinib as a strategy against Waldenström Macroglobulinemia. Clinical Cancer Research. 21:2538-2545.
    102. Differentiation of low-attenuation intracranial hemorrhage and calcification using dual-energy computed tomography in a phantom system. Investigative Radiology.
    103. Integrative Bayesian analysis of neuroimaging-genetic data through hierarchical dimension reduction. 824-828.
    104. Bayesian variable selection for linear regression in high dimensional microarray data. 17-18.
    105. Bayesian disease classification using copy number data. Cancer Informatics. 13:83-91.
    106. Undertaking an art survey to compare patient versus student art preferences. Environment and Behavior. 40:269-301.
    107. Bayesian approaches for large biological networks. 153-174.
    108. Classification, Predictive modelling, And statistical analysis of cancer data (A). Cancer Informatics. 13:1-3.
    109. Tight Junction Protein 1 Modulates Proteasome Capacity and Proteasome Inhibitor Sensitivity in Multiple Myeloma via EGFR/JAK1/STAT3 Signaling. Cancer Cell.
    110. A Two-Sample Test for Equality of Means in High Dimension. Journal of the American Statistical Association. 110:837-849.
    111. A semiparametric Bayesian model for comparing DNA copy numbers. Brazilian Journal of Probability and Statistics. 30:345-365.
    112. Spatial modeling of annual minimum and maximum temperatures in Iceland. Meteorology and Atmospheric Physics. 116:43-61.
    113. Integrating multi-platform genomic data using hierarchical Bayesian relevance vector machines. 18-21.
    114. Safety and activity of PD1 blockade by pidilizumab in combination with rituximab in patients with relapsed follicular lymphoma. The Lancet Oncology. 15:69-77.
    115. Association of CpG island methylator phenotype and EREG/AREG methylation and expression in colorectal cancer. British Journal of Cancer. 114:1352-1361.
    116. On the computation of stochastic search variable selection in linear regression with UDFs. 941-946.
    117. Selective Internal Radiation Therapy With Yttrium-90 Glass Microspheres. International Journal of Radiation Oncology Biology Physics. 96:888-896.
    118. Bayesian random segmentation models to identify shared copy number aberrations for array CGH data. Journal of the American Statistical Association. 105:1358-1375.
    119. Integrative Bayesian network analysis of genomic data. Cancer Informatics. 13:39-48.
    120. DEMARCATE. NeuroImage: Clinical. 12:132-143.
    121. Querying external source code files of programs connecting to a relational database. 9-16.
    122. Automated analysis of quantitative image data using isomorphic functional mixed models, with application to proteomics data. Annals of Applied Statistics. 5:894-923.
    123. Prediction-Oriented Marker Selection (PROMISE). Statistics in Biosciences. 1-29.
    124. Novel algorithmic approach predicts tumor mutation load and correlates with immunotherapy clinical outcomes using a defined gene mutation set. BMC Medicine. 14.
    125. Integrative Bayesian analysis of neuroimaging-genetic data with application to cocaine dependence. NeuroImage. 125:813-824.
    126. Latent feature decompositions for integrative analysis of multi-platform genomic data. IEEE/ACM Transactions on Computational Biology and Bioinformatics. 11:984-994.
    127. A nonparametric bayesian technique for high-dimensional regression. Electronic Journal of Statistics. 10:3374-3424.
    128. Bayesian sparse graphical models for classification with application to protein expression data. Annals of Applied Statistics. 8:1443-1468.
    129. Spatially adaptive Bayesian penalized regression splines (P-splines). Journal of Computational and Graphical Statistics. 14:378-394.
    130. Mir-21-Sox2 axis delineates glioblastoma subtypes with prognostic impact. Journal of Neuroscience. 35:15097-15112.
    131. Reduced rank mixed effects models for spatially correlated hierarchical functional data. Journal of the American Statistical Association. 105:390-400.
    132. Regulates paclitaxel sensitivity in ovarian cancer cells by modulating AKT ativation, p21Cip1- and p27Kip1-mediated G1 cell cycle arrest and apoptosis. PLoS One. 10.
    133. Functional CAR Models for Large Spatially Correlated Functional Datasets. Journal of the American Statistical Association. 111:772-786.
    134. Outcome of Patients with Multiple Myeloma and CKS1B Gene Amplification after Autologous Hematopoietic Stem Cell Transplantation. Biology of Blood and Marrow Transplantation. 22:2159-2164.
    135. Bayesian Analysis of Gene Expression Data.
    136. Nonparametric variable selection, clustering and prediction for large biological datasets. 175-192.
    137. Hierarchical Bayesian methods for integration of various types of genomics data. 5-8.
    138. Spatially adaptive Bayesian penalized regression splines (P-splines) (Journal of Computational and Graphical Statistics (2005) 14, 378-394). Journal of Computational and Graphical Statistics. 17:515.
    139. Lenalidomide, thalidomide, and pomalidomide reactivate the Epstein-Barr virus lytic cycle through phosphoinositide 3-kinase signaling and ikaros expression. Clinical Cancer Research. 22:4901-4912.
    140. Prognostic gene signature identification using causal structure learning. Cancer Informatics. 14:23-35.
    141. Bayesian sparse graphical models and their mixtures. Stat. 3:109-125.
    142. Latent feature decompositions for integrative analysis of diverse high-throughput genomic data. 130-134.
    143. Bayesian nonlinear model selection for gene regulatory networks. Biometrics. 71:585-595.
    144. Bayesian variable selection in linear regression in one pass for large datasets. ACM Transactions on Knowledge Discovery from Data. 9.
    145. PCAN. Biometrics.
    146. Bayesian hierarchical structured variable selection methods with application to molecular inversion probe studies in breast cancer. Journal of the Royal Statistical Society. Series C: Applied Statistics. 63:595-620.
    147. A fast convergence clustering algorithm merging MCMC and EM methods. 1525-1528.
    148. Data mining algorithms as a service in the cloud exploiting relational database systems. 1001-1004.
    149. Integrative analysis of multi-modal correlated imaging-genomics data in glioblastoma. 5-8.
    BALADANDAYUTHAPANI's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description